4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide

C27H35N9O3S — CID 11621082

IUPAC4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide
SMILESCCCCNS(=O)(=O)c1cccc(-n2nnc3cnc(Nc4ccc(C(=O)NCCN(CC)CC)cc4)nc32)c1
InChIInChI=1S/C27H35N9O3S/c1-4-7-15-30-40(38,39)23-10-8-9-22(18-23)36-25-24(33-34-36)19-29-27(32-25)31-21-13-11-20(12-14-21)26(37)28-16-17-35(5-2)6-3/h8-14,18-19,30H,4-7,15-17H2,1-3H3,(H,28,37)(H,29,31,32)
InChIKeyIOYWOOWPJUXQRO-UHFFFAOYSA-N
MW565.70 g/mol
LogP3.10
Rot. Bonds14

About 4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide

4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide (PubChem CID 11621082) has the molecular formula C27H35N9O3S and a molecular weight of 565.70 g/mol. Its IUPAC name is 4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide.

Molecular Properties

Compound Name4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide
PubChem CID11621082
Molecular FormulaC27H35N9O3S
Molecular Weight565.70 g/mol
Exact Mass565.26
IUPAC Name4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide
SMILESCCCCNS(=O)(=O)c1cccc(-n2nnc3cnc(Nc4ccc(C(=O)NCCN(CC)CC)cc4)nc32)c1
InChIInChI=1S/C27H35N9O3S/c1-4-7-15-30-40(38,39)23-10-8-9-22(18-23)36-25-24(33-34-36)19-29-27(32-25)31-21-13-11-20(12-14-21)26(37)28-16-17-35(5-2)6-3/h8-14,18-19,30H,4-7,15-17H2,1-3H3,(H,28,37)(H,29,31,32)
InChIKeyIOYWOOWPJUXQRO-UHFFFAOYSA-N
XLogP3.10
TPSA147.03 Ų
H-Bond Donors3
H-Bond Acceptors10
Rotatable Bonds14
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500565.70
LogP ≤ 53.10
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide?
The IUPAC name of 4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide (CID 11621082) is 4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide.
What is the SMILES notation for 4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide?
The canonical SMILES for 4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide is CCCCNS(=O)(=O)c1cccc(-n2nnc3cnc(Nc4ccc(C(=O)NCCN(CC)CC)cc4)nc32)c1.
What is the InChIKey of 4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide?
The InChIKey is IOYWOOWPJUXQRO-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H35N9O3S/c1-4-7-15-30-40(38,39)23-10-8-9-22(18-23)36-25-24(33-34-36)19-29-27(32-25)31-21-13-11-20(12-14-21)26(37)28-16-17-35(5-2)6-3/h8-14,18-19,30H,4-7,15-17H2,1-3H3,(H,28,37)(H,29,31,32).
What are the key properties of 4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide?
4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide has a molecular weight of 565.70 g/mol, XLogP of 3.10, 14 rotatable bonds, 3 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[3-[3-(butylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-5-yl]amino]-N-[2-(diethylamino)ethyl]benzamide is sourced from PubChem (CID 11621082), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).